Evaluating growth options as sources of value for pharmaceutical research projects

Article Abstract:

Decision trees have been used to present a quantitative assessment of compound growth options from research at pharmaceutical firm BestPharma. It is concluded that a decision tree is a valuable tool to show the key project risks and the key sources of value in a clear way.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

The allocation of resources for R&D in the world's leading pharmaceutical companies

Article Abstract:

The top ten among the 45 leading pharmaceutical companies have the highest R&D to sales ratio that has allowed them to have greater productivity in terms of larger staff and R&D expenditure allocated per New Chemical Entity. R&D spending among the 45 companies, which represent 78% of global investments on pharmaceuticals in 1992, were also found to be polarized. Only five companies allocated more than $900 million on R&D while most allocated less than $300 million.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Interpreting the sources of market value in a capital goods market: R&D management in industrial sensors

Article Abstract:

An integrated model for studying consumers' view of science-based products was developed. The model couples direct and indirect strategies for assessing a buyer's view of the relative importance of a product, with a new method of benchmarking called technometrics. A new measure for demand is presented, which indicates the extent to which a product's features matches those required by consumers. Several kinds of industrial pressure sensors are used to illustrate the model.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: